Profile data is unavailable for this security.
About the company
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd i is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and sales for Chinese and western medicine, chemical raw medicine, natural drug, biological medicine and intermediates of chemical raw medicine. The Company's Great Health segment includes the research, development, manufacturing and sales of beverages, foods, health products and other products. The Company's Great Commerce segment includes wholesale, retail, import and export for western medicine, Chinese medicine and medical apparatus and instruments. The Great Medical segment is engaged in medical services, traditional Chinese medicine health preservation, modern pension and medical equipment industry.
- Revenue in HKD (TTM)83.26bn
- Net income in HKD3.73bn
- Incorporated1997
- Employees28.05k
- LocationGuangzhou Baiyunshan Pharmaceutical Holdings Co LtdNo. 45 Shamian North StreetLiwan DistrictGUANGZHOU 510130ChinaCHN
- Phone+86 2 066281218
- Fax+86 2 066281229
- Websitehttp://www.gybys.com.cn/
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 17 Oct 2024 | 25.87m | 11.76% |
| LSV Asset Managementas of 31 Dec 2023 | 13.19m | 6.00% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 8.77m | 3.99% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 3.57m | 1.62% |
| HBM Partners AG (Investment Management)as of 31 Mar 2024 | 2.61m | 1.19% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.92m | 0.87% |
| Goldman Sachs Asset Management LPas of 03 Oct 2024 | 1.77m | 0.81% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 1.52m | 0.69% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2024 | 876.00k | 0.40% |
| Guolian Fund Management Co. Ltd.as of 30 Jun 2024 | 756.00k | 0.34% |
